Dunn John Michael is a director of Acer Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Acer Therapeutics Inc.
20 Nov 23
4
Acer Therapeutics Inc.
16 Mar 23
4
Acer Therapeutics Inc.
19 Jan 22
4
Acer Therapeutics Inc.
20 Jan 21
4
Acer Therapeutics Inc.
28 Jul 20
4
Acer Therapeutics Inc.
3 Jan 20
4
Acer Therapeutics Inc.
5 Feb 19
4
VITAL THERAPIES INC
14 Jan 19
4
VITAL THERAPIES INC
11 Jun 18
4
Acer Therapeutics Inc.
6 Oct 17
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Nov 23 | ACER Acer Therapeutics | Common Stock, $0.0001 par value per share | Sale back to company | Dispose D | No | No | 0 | 27,380 | 0.00 | 0 |